Marek Zatloukal,Vladimir Krystof,Libor Havlicek,Igor Popa,Karel Dolezal,Miroslav Strnad,Radek Jorda
申请号：
US13375343
公开号：
US20120070512A1
申请日:
2010.06.02
申请国别(地区):
US
年份:
2012
代理人:
摘要：
The invention relates to substituted 6-(2-hydroxybenzylamino)purines of general formula I, to their activity as cyclin-dependent kinases 2, 5, 7 and 9 inhibitors and to their use as medicaments, particularly in the treatment of disorders involving cell proliferation or inflammation. The invention further includes pharmaceutical compositions containing the substituted 6-(2-hydroxybenzylamino)purines.
